Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026

Go back to Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026
(NASDAQ: LTRN) Delayed: 3.78 -0.17 (4.3%)
Previous Close $3.95    52 Week High
Open $3.95    52 Week Low
Day High $4.09    P/E N/A 
Day Low $3.64    EPS
Volume 124,817